Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sun Pharma Advanced Research Co's
Operating Income
for the
three
months ended in Mar. 2026 was ₹17,708 Mil. Sun Pharma Advanced Research Co's Interest Expense for the
three
months ended in Mar. 2026 was ₹-116 Mil.
Sun Pharma Advanced Research Co's interest coverage for the quarter that ended in Mar. 2026 was 152.13.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sun Pharma Advanced Research Co's Interest Coverage or its related term are showing as below:
NSE:SPARC'
s Interest Coverage Range Over the Past 10 Years
Min: 46.54 Med: 46.54 Max: 46.54
Current: 46.54
NSE:SPARC's Interest Coverage is ranked better than 70.41% of 686
companies
in the Drug Manufacturers industry
Industry Median: 12.725
vs NSE:SPARC: 46.54
Sun Pharma Advanced Research Co (NSE:SPARC) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sun Pharma Advanced Research Co Interest Coverage Related Terms
Sun Pharma Advanced Research Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Sun Pharma Advanced Research Co Interest Coverage Chart
NSE:SPARC vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sun Pharma Advanced Research Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sun Pharma Advanced Research Co's Interest Coverage falls into.
Sun Pharma Advanced Research Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sun Pharma Advanced Research Co (NSE:SPARC) has a Interest Coverage of 152.13 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sun Pharma Advanced Research Co and its competitors. This is 227% above median its historical median of 46.54. Over the past decade, Sun Pharma Advanced Research Co's Interest Coverage has ranged from 46.54 to 46.54. According to the industry distribution chart, Sun Pharma Advanced Research Co ranks #203 out of 686 companies in the Drug Manufacturers industry, placing it in the top 29.6%.
Is Sun Pharma Advanced Research Co's Interest Coverage too high?
Sun Pharma Advanced Research Co's current Interest Coverage of 152.13 is 227% above median its 10-year median of 46.54. Over the past 10 years, this metric has ranged from a low of 46.54 to a high of 46.54. The Drug Manufacturers industry median Interest Coverage is 12.73. Sun Pharma Advanced Research Co's value of 152.13 is 1095.5% above this industry median. Based on the distribution chart, Sun Pharma Advanced Research Co ranks #203 out of 686 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sun Pharma Advanced Research Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sun Pharma Advanced Research Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sun Pharma Advanced Research Co ranks #203 out of 686 companies for Interest Coverage. This puts Sun Pharma Advanced Research Co in the upper half of its industry. The industry median Interest Coverage is 12.73. Sun Pharma Advanced Research Co's value of 152.13 is 1095.5% above this benchmark. Historically, Sun Pharma Advanced Research Co's own Interest Coverage has ranged from 46.54 to 46.54 over the past decade. While the company's 10-year median is 46.54 vs. the industry median of 12.73, Sun Pharma Advanced Research Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.73, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sun Pharma Advanced Research Co's current Interest Coverage of 152.13 is 1095.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sun Pharma Advanced Research Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sun Pharma Advanced Research Co's current Interest Coverage is 152.13, which is 227% above median its own 10-year median of 46.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharma Advanced Research Co stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co (NSE:SPARC) is currently considered Possible Value Trap. The stock's GF Value™ is ₹4,504.88, compared to a current price of ₹239.37 — trading 94.7% below its estimated fair value. The current Interest Coverage is 152.13, which is 227% above median its 10-year median of 46.54 and 1095.5% above the Drug Manufacturers industry median of 12.73. Sun Pharma Advanced Research Co's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sun Pharma Advanced Research Co (NSE:SPARC), the current Interest Coverage is 152.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sun Pharma Advanced Research Co (NSE:SPARC) Overvalued in 2026?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co stock appears to be undervalued.
The current stock price of ₹239.37 is trading 94.7% below its estimated GF Value™ of ₹4,504.88.
GuruFocus considers Sun Pharma Advanced Research Co to be Possible Value Trap.
Key valuation signals for NSE:SPARC:
Interest Coverage: 152.13 (227% above median its 10-year median of 46.54)
GF Value™: ₹4,504.88 vs. price of ₹239.37 (94.7% below fair value)
Industry Position: 1095.5% above the Drug Manufacturers median (#203 of 686)
No single metric tells the full story. See the NSE:SPARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sun Pharma Advanced Research Co Business Description
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
61GF Score
Get the complete analysis for NSE:SPARC
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SPARC has been successfully added to your 
